PMID- 36116086
OWN - NLM
STAT- MEDLINE
DCOM- 20230113
LR  - 20230203
IS  - 1099-1611 (Electronic)
IS  - 1057-9249 (Linking)
VI  - 32
IP  - 1
DP  - 2023 Jan
TI  - Feasibility and acceptability of written exposure therapy in addressing 
      posttraumatic stress disorder in Iranian patients with breast cancer.
PG  - 68-76
LID - 10.1002/pon.6037 [doi]
AB  - OBJECTIVE: This study examined the feasibility and acceptability of written 
      exposure therapy (WET) in reducing symptoms of posttraumatic stress disorder 
      (PTSD) in Iranian women with breast cancer. Secondary aims included examining the 
      influence of WET on quality of life (QoL), overgeneral memory and illness 
      perceptions. METHOD: Forty-six females with breast cancer and clinical symptoms 
      of PTSD referred to the Razi Hospital in Rasht, Iran were randomly assigned to 
      either WET (n = 23) or control (n = 23) groups. WET is a 5-session low-intensity 
      exposure-based intervention for treating PTSD. The control group had no 
      additional contact. Measures assessing PTSD, illness perceptions, overgeneral 
      memory, and QoL were administered at baseline, post-intervention and 3-month 
      follow-up. RESULTS: Acceptability of WET was high; all participants completed all 
      WET sessions. At post-intervention, 95.65% of the WET group met criteria for 
      reliable change and 100% met criteria for minimal clinically important difference 
      (MCID) and clinically significant change in PTSD symptom improvement. At 
      follow-up, all WET participants met criteria for reliable change, MCID and 
      clinically significant change in PTSD symptom improvement. No participants in the 
      control group met reliable change, MCID or clinically significant change. The WET 
      group had improved QoL and memory specificity and decreased threatening illness 
      perceptions at post-intervention and follow-up when compared to controls. 
      CONCLUSION: WET may be a useful intervention for use with breast cancer patients 
      with PTSD symptoms and may be an important adjunct to medical and pharmacological 
      treatments, particularly in low- and middle-income countries. This study 
      indicates further research in this area is warranted.
CI  - (c) 2022 John Wiley & Sons Ltd.
FAU - Zolfa, Reihane
AU  - Zolfa R
AD  - Department of Clinical Psychology, Kharazmi University, Tehran, Iran.
FAU - Moradi, Alireza
AU  - Moradi A
AD  - Kharazmi University and Institute for Cognitive Science Studies, Tehran, Iran.
FAU - Mahdavi, Mohammad
AU  - Mahdavi M
AD  - Kharazmi University and Institute for Cognitive Science Studies, Tehran, Iran.
FAU - Parhoon, Hadi
AU  - Parhoon H
AD  - Department of Psychology, Razi University, Kermanshah, Iran.
FAU - Parhoon, Kamal
AU  - Parhoon K
AD  - Postdoc Researcher in Cognitive Psychology, Kharazmi University, Tehran, Iran.
FAU - Jobson, Laura
AU  - Jobson L
AUID- ORCID: 0000-0002-1534-897X
AD  - Turner Institute for Brain and Mental Health, Monash University, Melbourne, 
      Australia.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20220928
PL  - England
TA  - Psychooncology
JT  - Psycho-oncology
JID - 9214524
SB  - IM
MH  - Humans
MH  - Female
MH  - *Stress Disorders, Post-Traumatic/therapy/diagnosis
MH  - *Implosive Therapy
MH  - Iran
MH  - Quality of Life
MH  - *Breast Neoplasms/therapy
MH  - Feasibility Studies
OTO - NOTNLM
OT  - LMIC
OT  - PTSD
OT  - autobiographical memory
OT  - breast cancer
OT  - illness perception
OT  - oncology
OT  - quality of life
OT  - written exposure therapy
EDAT- 2022/09/19 06:00
MHDA- 2023/01/14 06:00
CRDT- 2022/09/18 13:54
PHST- 2022/07/18 00:00 [revised]
PHST- 2022/02/12 00:00 [received]
PHST- 2022/07/26 00:00 [accepted]
PHST- 2022/09/19 06:00 [pubmed]
PHST- 2023/01/14 06:00 [medline]
PHST- 2022/09/18 13:54 [entrez]
AID - 10.1002/pon.6037 [doi]
PST - ppublish
SO  - Psychooncology. 2023 Jan;32(1):68-76. doi: 10.1002/pon.6037. Epub 2022 Sep 28.